$AMGN·4

AMGEN INC · Mar 7, 5:23 PM ET

AMGEN INC 4

4 · AMGEN INC · Filed Mar 7, 2014

Insider Transaction Report

Form 4
Period: 2014-03-06
Transactions
  • Exercise/Conversion

    Nqso (Right to Buy)

    2014-03-065,0000 total
    Exercise: $58.43From: 2011-04-26Exp: 2020-04-26Common Stock (5,000 underlying)
  • Exercise/Conversion

    Common Stock

    2014-03-06$58.43/sh+5,000$292,15020,364 total
  • Exercise/Conversion

    Common Stock

    2014-03-06$50.44/sh+5,000$252,20025,364 total
  • Tax Payment

    Common Stock

    2014-03-06$126.19/sh6,021$759,79019,343 total
  • Sale

    Common Stock

    2014-03-06$126.69/sh1,000$126,69018,343 total
  • Exercise/Conversion

    Nqso (Right to Buy)

    2014-03-065,0000 total
    Exercise: $50.44From: 2010-04-28Exp: 2016-04-28Common Stock (5,000 underlying)
Footnotes (2)
  • [F1]All shares were sold at $126.69.
  • [F2]These shares include 95 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT